Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,969 | 11,328 | 3,027 | 3,503 | 329 |
| Marketable Securities | 1,600 | N/A | N/A | N/A | 4,786 |
| Receivables | 450 | 831 | 792 | 910 | 502 |
| TOTAL | $11,107 | $12,207 | $3,853 | $4,446 | $5,672 |
| Non-Current Assets | |||||
| PPE Net | 272 | 302 | 327 | 258 | 267 |
| Other Non-Current Assets | 21 | 15 | 13 | 22 | 273 |
| TOTAL | $293 | $317 | $340 | $280 | $540 |
| Total Assets | $11,400 | $12,524 | $4,193 | $4,726 | $6,212 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,579 | 1,027 | 573 | 455 | 676 |
| Accrued Expenses | 816 | 755 | 1,034 | 877 | 710 |
| TOTAL | $2,395 | $1,782 | $1,607 | $1,332 | $1,386 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 104 | 142 | 1,726 | 655 | 291 |
| TOTAL | $104 | $142 | $1,726 | $655 | $291 |
| Total Liabilities | $2,499 | $1,924 | $3,333 | $1,987 | $1,677 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,019 | 1,011 | 813 | 784 | 784 |
| Common Shares | 10 | 10 | 8 | 8 | 8 |
| Retained earnings | -58,923 | -56,502 | -54,518 | -52,407 | -51,190 |
| TOTAL | $8,901 | $10,600 | $860 | $2,739 | $4,535 |
| Total Liabilities And Equity | $11,400 | $12,524 | $4,193 | $4,726 | $6,212 |